tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Cautious Hold Rating on Shield Therapeutics Amidst Positive Financials and Prescription Growth Concerns
RatingsCautious Hold Rating on Shield Therapeutics Amidst Positive Financials and Prescription Growth Concerns
2d ago
Shield Therapeutics CEO Increases Stake, Signaling Confidence in Company’s Strategic Direction
PremiumCompany Announcements
Shield Therapeutics CEO Increases Stake, Signaling Confidence in Company’s Strategic Direction
8d ago
Shield Therapeutics Grants Share Options to New CEO to Strengthen Market Position
PremiumCompany Announcements
Shield Therapeutics Grants Share Options to New CEO to Strengthen Market Position
8d ago
Shield Therapeutics Hold Rating: Balancing Revenue Growth with Prescription Challenges and Financial Uncertainty
PremiumRatings
Shield Therapeutics Hold Rating: Balancing Revenue Growth with Prescription Challenges and Financial Uncertainty
15d ago
Shield Therapeutics Sees Revenue Surge Amid Strategic Initiatives
PremiumCompany Announcements
Shield Therapeutics Sees Revenue Surge Amid Strategic Initiatives
16d ago
Shield Therapeutics Appoints Anders Lundstrom as Permanent CEO
PremiumCompany AnnouncementsShield Therapeutics Appoints Anders Lundstrom as Permanent CEO
25d ago
Shield Therapeutics Secures $10 Million Funding and Expands Share Capital
Premium
Company Announcements
Shield Therapeutics Secures $10 Million Funding and Expands Share Capital
2M ago
Shield Therapeutics Raises Funds through RetailBook Offer
Premium
Company Announcements
Shield Therapeutics Raises Funds through RetailBook Offer
2M ago
Shield Therapeutics Announces New RetailBook Share Offer
PremiumCompany Announcements
Shield Therapeutics Announces New RetailBook Share Offer
3M ago
Shield Therapeutics Aims for Financial Boost through Share Subscription
PremiumCompany Announcements
Shield Therapeutics Aims for Financial Boost through Share Subscription
3M ago
Shield Therapeutics Reports Strong ACCRUFeR® Sales and Study Progress
PremiumCompany Announcements
Shield Therapeutics Reports Strong ACCRUFeR® Sales and Study Progress
3M ago
Shield Therapeutics Sees Revenue Surge and Financial Boost
PremiumCompany Announcements
Shield Therapeutics Sees Revenue Surge and Financial Boost
4M ago
Shield Therapeutics’ Pediatric IDA Trial Succeeds
PremiumCompany AnnouncementsShield Therapeutics’ Pediatric IDA Trial Succeeds
5M ago
Shield Therapeutics Sees Strong Revenue Growth
Premium
Company Announcements
Shield Therapeutics Sees Strong Revenue Growth
6M ago
Shield Therapeutics’ Iron Drug Wins Canada Approval
Premium
Company Announcements
Shield Therapeutics’ Iron Drug Wins Canada Approval
6M ago
Shield Therapeutics Readies H1 2024 Results
PremiumCompany Announcements
Shield Therapeutics Readies H1 2024 Results
6M ago
Shield Therapeutics Sees Surge in Q2 Revenue
PremiumCompany Announcements
Shield Therapeutics Sees Surge in Q2 Revenue
7M ago
Shield Therapeutics Appoints New Interim CEO
PremiumCompany Announcements
Shield Therapeutics Appoints New Interim CEO
7M ago
Shield Therapeutics AGM Yields Strong Support
PremiumCompany Announcements
Shield Therapeutics AGM Yields Strong Support
8M ago
Shield Therapeutics Eyes Expansion in Korea
PremiumCompany AnnouncementsShield Therapeutics Eyes Expansion in Korea
9M ago
Shield Therapeutics Reports Revenue Surge and Reduced Losses
Premium
Company Announcements
Shield Therapeutics Reports Revenue Surge and Reduced Losses
10M ago
Shield Therapeutics on Track for Positive Cashflow by 2025
Premium
Company Announcements
Shield Therapeutics on Track for Positive Cashflow by 2025
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >